Ajax-Loading

Takeda Pharmaceutical Co. Ltd. - Net Receivables

Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.

The item "Net-Receivables" stands at 688.96 Billion Japanese Yens as of 09/30/2025.

As of the end of Takeda Pharmaceutical Co. Ltd.'s second quarter, the item "Net Receivables" stands at 688.96 Billion JPY. This represents an increase of 1.39 percent compared to it's value at the end of it's first quarter .


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -4.45 percent compared to the value the year prior.
The 1 year change in percent is -4.45.
The 3 year change in percent is -13.94.
The 5 year change in percent is -10.50.
The 10 year change in percent is 46.04.

The Serie's long term average value is 602.93 Billion Japanese Yens. It's latest available value, on 09/30/2025, is 14.27 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 03/31/2013, to it's latest available value, on 09/30/2025, is +101.24%.
The Serie's change in percent from it's maximum value, on 09/30/2021, to it's latest available value, on 09/30/2025, is -22.35%.

Net Receivables for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Net Receivables905,699,262,464.00
LogoJohnson & Johnson - Net Receivables486,508,953,600.00
LogoAbbVie Inc - Net Receivables399,570,305,024.00
LogoRoche Holding AG - Net Receivables317,433,206,677.55
LogoAstraZeneca PLC - Net Receivables280,205,508,085.11